• kids side
  • girls
  • mother1 daughter
  • New resources for patients at risk
  • kids eating
  • kids leaning
  • mother kids
  • kids run
  • kids food
  • kids computing
  • track

Eosinophilic Oesophagitis

pdfAER Eosinophilic Oesophagitis 2014206.09 KB

Eosinophilic oesophagitis (EoE) results in an inflamed oesophagus, the muscular tube that connects the mouth to the stomach. Most cases are seen in people with other allergies such as allergic rhinitis (hay fever) and asthma. The frequency of eosinophilic oesophagitis appears to be increasing. The reasons are unclear, but it is known that allergies of all types have become more common.

Eosinophilic Oesophagitis is increasing

The exact prevalence in adults is uncertain, but it is estimated to affect 1 per 10,000 children and approximately 1 per cent of adults in Australia.

What is an eosinophil?

An eosinophil is a type of white blood cell that also causes the allergic type of inflammation seen in allergic rhinitis (hay fever) and asthma.

What is eosinophilic oesophagitis?

In eosinophilic oesophagitis the lining of the oesophagus is infiltrated with eosinophils. This can result in abnormal function of the oesophagus and symptoms of heart burn.

The condition affects mainly children and young adults

Eosinophilic oesophagitis has been described mainly in children and young adults. It should be suspected when a person complains of:

  • Foods sticking on the way down, sometimes completely;
  • Choking on food;
  • Regurgitation of foods;
  • Severe acid reflux (heartburn) that does not respond to medicines used to suppress stomach acid production.

If left untreated, the condition can result in permanent scarring of the oesophagus. It should be noted that mild reflux and vomiting are common in children and adults, and most do not have eosinophilic oesophagitis.

How is Eosinophilic oesophagitis diagnosed?

If a diagnosis of eosinophilic oesophagitis is suspected by your treating doctor, confirmation by examination of your oesophagus using an instrument known as an endoscope is required. A tissue sample (biopsy) will be taken at the same time and examined to look for the presence of eosinophils. Endoscopy and biopsy is normally performed by a gastroenterologist (stomach/bowel medical specialist). Sometimes a blood sample will show a higher than normal level of eosinophils in the blood as well.

Eosinophilic oesophagitis may result from pollen or food allergy

Around 80 per cent of people with eosinophilic oesophagitis also have other allergic conditions such as allergic rhinitis (hay fever) or asthma. When allergy testing is performed, many will have positive skin prick tests or patch tests to foods, even when there are no obvious symptoms after they are consumed. When food is involved, staples such as cow's milk (dairy products), wheat, meats, soy and egg seem to be the most common triggers. Some researchers have found that people benefit if these foods are removed from the diet. Others have found that symptoms appear only during springtime when people are exposed

to pollens.

Who treats this condition?

Most people with eosinophilic oesophagitis are managed by gastroenterologists. Recognising that allergy may also play a role in some patients, many are managed by clinical immunology/allergy specialists as well as specialist dietitians.

Treatment options

Time
Symptoms in infants may resolve in the first few years of life, particularly when only 1 or 2 foods are involved. Unfortunately, when symptoms arise in older children and adults, they usually last for many years. Follow up studies so far indicate that they do not seem to resolve in these groups, but more long term follow up studies may provide more information.

Medication

  • Medication to reduce acid production will reduce acid reflux and the scarring that can result.
  • Topical asthma steroid puffers can reduce inflammation in the oesophagus. These are swallowed instead of inhaled, are low dose, poorly absorbed, and extremely unlikely to cause cortisone/steroid tablet like side effects. They help reduce inflammation and the scarring that can result from untreated disease.
  • Montelukast (Singulair) is an asthma tablet that reduces inflammation by blocking the effects of inflammatory chemicals known as leukotrienes released by white cells.
  • Other medicines are also being studied.

Dilation

Sometimes if the oesophagus is very narrow, an endoscopy and a procedure known as dilation may be required to open up the oesophagus to allow food to pass more easily.

Diet manipulation

Dietary manipulation should be undertaken under the direction of a medical specialist and supervision of a specialist dietitian. Dietary manipulation may assist both adults and children. When undertaking dietary manipulation, the foods are removed for a period of time and then re-introduced one at a time to see which foods result in symptom recurring.

Types of dietary manipulation commonly used include:

  • Common food allergen elimination diet – this usually includes the removal of cow’s milk, soy, egg, wheat, peanuts, tree nuts, fish and shellfish. Allergy testing or patient history may result in the removal of additional foods.
  • Directed diets – foods are removed based on the history of trigger foods and allergy testing.
  • Amino acid based diets – this diet is based on amino acid formula and is impractical in adults and most older children.

Endoscopies and repeat biopsies may be needed to monitor the response to treatment. It is important to note that:

  • Diagnosis of eosinophilic oesophagitis should always be confirmed first by endoscopy and biopsy.
  • Dietary manipulation should be temporary, initiated by a medical specialist and supervised by a skilled dietitian to avoid the risk of malnutrition.

Not all eosinophilic oesophagitis is related to allergy

Around a quarter of people with eosinophilic oesophagitis have no evidence of an allergic reaction, some have underlying conditions that can cause similar inflammation in the gut. These people will not respond to diet manipulation, but may respond to medication.

This is a developing area of research

As eosinophilic oesophagitis is a developing area of research more is being discovered about this condition. There are controversies as to the role of allergy and diet manipulation, and how many people are actually helped by diet. Furthermore, sometimes symptoms may improve with diet manipulation, but the underlying inflammation can still persist. At this time it is not clear how aggressive treatment should be in all cases; should we aim to settle the symptoms, or try to control the underlying inflammation as well? More people are being reported with symptoms during the pollen season, suggesting that inhaled allergen (or perhaps swallowed pollen) may cause problems in some people.

Other Resources and Web Links

American Partnership for Eosinophilic Disorders: www.apfed.org

Australian Support Network for Eosinophilic Oesophagitis and related disorders: www.ausee.org

© ASCIA 2014

The Australasian Society of Clinical Immunology and Allergy (ASCIA) is the peak professional body of Clinical Immunologists and Allergists in Australia and New Zealand.

Website: www.allergy.org.au

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Postal address: PO Box 450 Balgowlah NSW Australia 2093

Disclaimer

This document has been developed and peer reviewed by ASCIA members and is based on expert opinion and the available published literature at the time of review. Information contained in this document is not intended to replace medical advice and any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner.

The development of this document is not funded by any commercial sources and is not influenced by commercial organisations.

References

1. Heine RG, Nethercote M, Rosenbaum J, Allen KJ. Emerging Management Concepts for Eosinophilic Esophagitis in Children. J Gastroenterol Hepatol. 2011; 26 (7): 1106-1113.

2. Cantu, P., et al., Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases. Dig Liver Dis, 2005. 37(2): p. 129-34

3. Straumann, A. and H.U. Simon, Eosinophilic esophagitis: Escalating epidemiology? J Allergy Clin Immunol, 2005. 115(2): p. 418-9.

4. Spergel, J.M. and T. Brown-Whitehorn, The Use of Patch Testing in the Diagnosis of Food Allergy. Curr Allergy Asthma Rep, 2005. 5(1): p. 86-90.

5. Lucendo, A.J., et al., Eosinophilic esophagitis in adults: an emerging disease. Dig Dis Sci, 2004. 49(11-12): p. 1884-8.

6. Nostrant, T.T., Esophageal Dilation / Dilators. Curr Treat Options Gastroenterol, 2005. 8(1): p. 85-95.

7. Mann, N.S. and J.W. Leung, Pathogenesis of esophageal rings in eosinophilic esophagitis. Med Hypotheses, 2005. 64(3): p. 520-3.

8. Sant'Anna, A.M., et al., Eosinophilic Esophagitis in Children: Symptoms, Histology and pH Probe Results. J Pediatr Gastroenterol Nutr, 2004. 39(4): p. 373-377. • Straumann, A., et al., Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion, 2004. 70(2): p. 109-16.

9. Liacouras, C.A. and E. Ruchelli, Eosinophilic esophagitis. Curr Opin Pediatr, 2004. 16(5): p. 560-6.

10. Noel, R.J., P.E. Putnam, and M.E. Rothenberg, Eosinophilic esophagitis. N Engl J Med, 2004. 351(9): p. 940-1.

11. Evrard, S., et al., Idiopathic eosinophilic oesophagitis: atypical presentation of a rare disease. Acta Gastroenterol Belg, 2004. 67(2): p. 232-5.

12. Dahms, B.B., Reflux esophagitis: sequelae and differential diagnosis in infants and children including eosinophilic esophagitis. Pediatr Dev Pathol, 2004. 7(1): p. 5-16.

13. Langdon, D.E., Response to Straumann et al.: primary eosinophilic esophagitis. Gastroenterology, 2004. 127(1): p. 364; author reply 364-5.

14. Noel, R.J., et al., Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol, 2004. 2(7): p. 568-75.

15. Arora, A.S. and K. Yamazaki, Eosinophilic esophagitis: asthma of the esophagus? Clin Gastroenterol Hepatol, 2004. 2(7): p. 523-30.

16. Gawrieh, S. and R. Shaker, Treatment options for eosinophilic esophagitis: montelukast. Curr Gastroenterol Rep, 2004. 6(3): p. 190. • Gawrieh, S. and R. Shaker, Treatment options for eosinophilic esophagitis: elemental diet. Curr Gastroenterol Rep, 2004. 6(3): p. 189.

17. Heine, R.G., Pathophysiology, diagnosis and treatment of food protein-induced gastrointestinal diseases. Curr Opin Allergy Clin Immunol, 2004. 4(3): p. 221-9.

18. Esposito, S., et al., Long-term follow-up of symptoms and peripheral eosinophil counts in seven children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr, 2004. 38(4): p. 452-6.

19. Nurko, S., et al., Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr, 2004. 38(4): p. 436-41.

20. Teitelbaum, J.E., Natural history of primary eosinophilic esophagitis: a follow up of 30 adult patients for up to 11.5 years. J Pediatr Gastroenterol Nutr, 2004. 38(3): p. 358-9.

21. Dahms, B.B., Reflux Esophagitis: Sequelae and Differential Diagnosis in Infants and Children Including Eosinophilic Esophagitis. Pediatr Dev Pathol, 2004. 7(1).

22. Potter, J.W., et al., Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc, 2004. 59(3): p. 355-61.

23. Straumann, A., et al., Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology, 2003. 125(6): p. 1660-9.

24. Rothenberg, M.E., Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol, 2004. 113(1): p. 11-28; quiz 29.

25. Garrett, J.K., et al., Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol, 2004. 113(1): p. 115-9.

26. Liacouras, C.A., Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr, 2003. 37 Suppl 1: p. S23-8. • Fogg, M.I., E. Ruchelli, and J.M. Spergel, Pollen and eosinophilic esophagitis. J Allergy Clin Immunol, 2003. 112(4): p. 796-7.

27. Markowitz, J.E. and C.A. Liacouras, Eosinophilic esophagitis. Gastroenterol Clin North Am, 2003. 32(3): p. 949-66.

28. Croese, J., et al., Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc, 2003. 58(4): p. 516-22.

29. Cheung, K.M., et al., Esophageal eosinophilia in children with dysphagia. J Pediatr Gastroenterol Nutr, 2003. 37(4): p. 498-503.

30. Sinharay, R., Eosinophilic oesophagitis: treatment using Montelukast. Gut, 2003. 52(8): p. 1228-9.

31. Arora, A.S., J. Perrault, and T.C. Smyrk, Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc, 2003. 78(7): p. 830-5.

32. Munitiz, V., et al., Primary eosinophilic esophagitis. Dis Esophagus, 2003. 16(2): p. 165-8.

33. Sicherer, S.H., Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics, 2003. 111(6 Pt 3): p. 1609-16.

34. Markowitz, J.E., et al., Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol, 2003. 98(4): p. 777-82.

35. Katzka, D.A., Eosinophilic Esophagitis. Curr Treat Options Gastroenterol, 2003. 6(1): p. 49-54.

36. Fox, V.L., et al., High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc, 2003. 57(1): p. 30-6.

37. Elitsur, Y., Learning more about eosinophilic esophagitis. J Pediatr Gastroenterol Nutr, 2002. 35(5): p. 711-2.

38. Fujiwara, H., et al., Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis. Ann Allergy Asthma Immunol, 2002. 89(4): p. 429-32.

39. Khan, S. and W.A. Henderson, Treatment of Eosinophilic Esophagitis in Children. Curr Treat Options Gastroenterol, 2002. 5(5): p. 367-376.

40. Khan, S. and S.R. Orenstein, Eosinophilic gastroenteritis: epidemiology, diagnosis and management. Paediatr Drugs, 2002. 4(9): p. 563-70.

41. Teitelbaum, J.E., et al., Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology, 2002. 122(5): p. 1216-25.

42. Elitsur, Y., Eosinophilic esophagitis--is it in the air? J Pediatr Gastroenterol Nutr, 2002. 34(3): p. 325-6; author reply 326.

43. Furuta, G.T., Eosinophilic esophagitis: an emerging clinicopathologic entity. Curr Allergy Asthma Rep, 2002. 2(1): p. 67-72.

44. Spergel, J.M., et al., The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol, 2002. 109(2): p. 363-8.

45. De Agustin, J.C., et al., Successful medical treatment of two patients with eosinophilic oesophagitis. J Pediatr Surg, 2002. 37(2): p. 207-13

46. Straumann, A., et al., Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol, 2001. 108(6): p. 954-61.

47. Rothenberg, M.E., et al., Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol, 2001. 108(6): p. 891-4.

48. Vanderhoof, J.A. and R.J. Young, Allergic disorders of the gastrointestinal tract. Curr Opin Clin Nutr Metab Care, 2001. 4(6): p. 553-6.

49. Spergel JM, Beausoleil J, Brown-Whitehorn T, Liacouras CA. Authors' response to detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol. 2006 Feb;96(2):376-8.

50. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Flick J, Kelly J, Brown-Whitehorn T, Mamula P, Markowitz JE. ­Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005 Dec;3(12):1198-206.

51. Dauer EH, Freese DK, El-Youssef M, Thompson DM. Clinical characteristics of eosinophilic esophagitis in children. Ann Otol Rhinol Laryngol. 2005 Nov;114(11):827-33.

52. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005 Oct;95(4):336-43.

53. Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006 Jan;19(1):90-6.

54. Aceves SS, Dohil R, Newbury RO, Bastian JF. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis.­J Allergy Clin Immunol. 2005 Sep;116(3):705-6.

55. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005 Jun;61(7):795-801.

56. Onbasi K et al. Eosinophilic infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clinical Experimental Allergy 2005; 35: 1421-31.

 

Content last updated January 2014

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

 

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information: verify here.


World Allergy Organization (WAO)

ASCIA is a WAO member society